PNC Financial Services Group’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-2,000
| Closed | – | – | 4199 |
|
|
2019
Q4 | $0 | Buy |
+2,000
| New | – | ﹤0.01% | 4234 |
|
|
2018
Q3 | – | Sell |
-100
| Closed | -$1K | – | 4326 |
|
|
2018
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 4108 |
|
|
2018
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 4158 |
|
|
2017
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 4118 |
|
|
2017
Q3 | $1K | Sell |
100
-330
| -77% | -$3.4K | ﹤0.01% | 4108 |
|
|
2017
Q2 | $5K | Buy |
430
+330
| +330% | +$3.9K | ﹤0.01% | 3830 |
|
|
2017
Q1 | $1K | Buy |
+100
| New | +$1.07K | ﹤0.01% | 4076 |
|
|
2016
Q4 | – | Sell |
-800
| Closed | -$10K | – | 4164 |
|
|
2016
Q3 | $10K | Sell |
800
-168
| -17% | -$2.55K | ﹤0.01% | 3496 |
|
|
2016
Q2 | $12K | Sell |
968
-7
| -0.7% | -$102 | ﹤0.01% | 3495 |
|
|
2016
Q1 | $15K | Sell |
975
-619
| -39% | -$11.8K | ﹤0.01% | 3408 |
|
|
2015
Q4 | $45K | Buy |
1,594
+648
| +68% | +$18K | ﹤0.01% | 2899 |
|
|
2015
Q3 | $26K | Sell |
946
-14,984
| -94% | -$551K | ﹤0.01% | 3236 |
|
|
2015
Q2 | $572K | Buy |
15,930
+3,048
| +24% | +$94.9K | ﹤0.01% | 1564 |
|
|
2015
Q1 | $375K | Hold |
12,882
| – | – | ﹤0.01% | 1830 |
|
|
2014
Q4 | $271K | Buy |
12,882
+6,082
| +89% | +$120K | ﹤0.01% | 1896 |
|
|
2014
Q3 | $132K | Buy |
+6,800
| New | +$107K | ﹤0.01% | 2236 |
|
PNC Financial Services Group's INSY Position: Q1 2020 in Review
PNC Financial Services Group sold out of Insys Therapeutics, Inc. (INSY) in Q1 2020, closing a stake of 2,000 shares.
PNC Financial Services Group first reported a position in INSY in Q3 2014 and held it in 16 quarters. The position peaked at $572K in Q2 2015. 1 fund tracked by Wall St. Rank holds INSY as of Q1 2020.
- PNC Financial Services Group reported no remaining Insys Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
- PNC Financial Services Group sold 2,000 Insys Therapeutics, Inc. shares in Q1 2020.
- PNC Financial Services Group first reported a position in Insys Therapeutics, Inc. in Q3 2014 and held it in 16 quarters.
- PNC Financial Services Group's Insys Therapeutics, Inc. position peaked at $572K in Q2 2015.
- 1 fund tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2020.
Based on PNC Financial Services Group's 13F filing for Q1 2020, filed 8 May 2020.